Drug-Likeness and ADMET Evaluation of Garlic Non-Sulfur Compounds: A Virtual Screening Approach
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
In modern drug discovery, where some of the most important aspects remain lead compound identification and screening; computational approaches therefore stand out. Here, we systematically compiled and evaluated a library of 18 phytoconstituents from non-sulfur compounds of garlic. The compounds were first screened for their drug-likeness according to Lipinski’s Rule of Five and ADMET predictions of the parameters that greatly affect the pharmacological activity of a drug candidate were investigated. All the compounds were meticulously studied for their pharmacokinetic and pharmacodynamic profiles which were compared with standard anticancer drug paclitaxel. These findings suggest that among 18 investigated compounds, gamma-octalactone showed optimal characteristics and was identified as the best candidate for future drug development.
Fields of Study & Subjects
Computational Drug Discovery Methods
Garlic and Onion Studies
Medicinal Plant Research
Publication details
- Journal / source
- International Journal for Research in Applied Science and Engineering Technology
- Volume
- 14
- Issue
- 3
- Pages
- 3679–3692
- Publication date
- 28 March 2026
- Language
- EN